November 25, 2023 | BALTIMORE – Complete Omics management team are thrilled to announce a significant milestone for our company – a recent investment by Qiming Venture Partners. This partnership marks a pivotal moment in our journey, as we continue to advance our clinical proteomics platform and molecular diagnostics platform development. With this investment, we are poised to accelerate our efforts in bringing innovative solutions to the healthcare industry, ultimately aiming to improve patient outcomes through cutting-edge diagnostics.
Founded in 2006, Qiming Venture Partners is a leading venture capital firm in China, boasting an impressive track record of supporting fast-growing and innovative companies. With offices in Shanghai, Beijing, Suzhou, Hong Kong, and Singapore, Qiming manages eleven US Dollar funds and seven RMB funds, totaling $9.5 billion in capital raised. Their expertise and resources have been pivotal in the growth and success of over 530 companies across the Technology and Consumer (T&C) and Healthcare industries. Notably, over 200 of their portfolio companies have achieved exits through IPOs or M&A, with more than 70 reaching unicorn status. Their portfolio includes influential firms such as Xiaomi, Meituan, Bilibili, Zhihu, Roborock, Gan & Lee Pharmaceuticals, and many others.
The backing of Qiming Venture Partners is not just a financial investment but a strong vote of confidence in our technology, our team, and our vision for the future of healthcare. It’s an affirmation of our potential to make a significant impact in the industry, backed by a partner with a proven track record of nurturing successful companies.
As we embark on this exciting new chapter, we are more committed than ever to our mission of revolutionizing healthcare through our clinical proteomics and molecular diagnostics platforms. We look forward to leveraging Qiming Venture Partners’ vast experience, network, and resources to accelerate our growth and expand our impact.
We are incredibly grateful for the trust and support of Qiming Venture Partners and are excited about the possibilities that this partnership brings. Together, we are set to redefine the landscape of healthcare diagnostics and improve the lives of patients around the globe.
Stay tuned for more updates on our progress and the groundbreaking advancements we’re working on. Here’s to a future where advanced diagnostics and personalized medicine become the standard, not the exception.
Thank you to everyone who has supported us on this journey. The best is yet to come!
